ScholarIQanswers from OpenAlex & ORCID
Yoon Kyung Jeon
ResearcherPublications, citations & collaboration network
Yoon Kyung Jeon is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Yoon Kyung Jeon have?
ScholarIQindexed works
Yoon Kyung Jeon has 486 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Yoon Kyung Jeon have?
ScholarIQcitation count
Yoon Kyung Jeon has 13,725 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Yoon Kyung Jeon?
ScholarIQh-index
Yoon Kyung Jeon has an h-index of 63 in OpenAlex.
What is the i10-index of Yoon Kyung Jeon?
ScholarIQi10-index
Yoon Kyung Jeon has an i10-index of 212 in OpenAlex.
What is the ORCID of Yoon Kyung Jeon?
ScholarIQorcid
The ORCID for Yoon Kyung Jeon is on the source record.
What is the OpenAlex record for Yoon Kyung Jeon?
ScholarIQopenalex
The OpenAlex for Yoon Kyung Jeon is on the source record.
What are the most-cited papers on Yoon Kyung Jeon?
ScholarIQmost cited works
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas
Jake June-Koo Lee, Junehawk Lee, Sehui Kim, Soyeon Kim, Jeonghwan Youk, Seongyeol Park, Yohan An, Bhumsuk Keam, Dong‐Wan Kim, Dae Seog Heo, Young Tae Kim, Jin-Soo Kim, Se Hyun Kim, Jong Seok Lee, Se‐Hoon Lee, Keunchil Park, Ja‐Lok Ku, Yoon Kyung Jeon, Doo Hyun Chung, Peter J. Park, Joon Kim, Tae‐Min Kim, Young Seok Ju
Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration
Chan-Young Ock, Bhumsuk Keam, Sehui Kim, Ju‐Seog Lee, Miso Kim, Tae Min Kim, Yoon Kyung Jeon, Dong‐Wan Kim, Doo Hyun Chung, Dae Seog Heo
Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis
Hoibin Jeong, Sehui Kim, Beom-Ju Hong, Chan-Ju Lee, Young-Eun Kim, Seoyeon Bok, Jung-Min Oh, Seung-Hee Gwak, Min Young Yoo, Min Sun Lee, Seock‐Jin Chung, Joan Defrêne, Philippe A. Tessier, Martin Pelletier, Hyeongrin Jeon, Tae‐Young Roh, Bumju Kim, Ki Hean Kim, Ji Hyeon Ju, Sungjee Kim, Yoon‐Jin Lee, Dong-Wan Kim, Il Han Kim, Hak Jae Kim, Jong‐Wan Park, Yun‐Sang Lee, Jae Sung Lee, Gi Jeong Cheon, Irving L. Weissman, Doo Hyun Chung, Yoon Kyung Jeon, G‐One Ahn
Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation
Sae‐Won Han, Tae‐You Kim, Yoon Kyung Jeon, Pil Gyu Hwang, Seock‐Ah Im, Kyung-Hun Lee, Jee Hyun Kim, Dong‐Wan Kim, Dae Seog Heo, Noe Kyeong Kim, Doo Hyun Chung, Yung‐Jue Bang
Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial
Se‐Hoon Lee, Jake June-Koo Lee, Myung‐Ju Ahn, Dongwook Kim, Jong‐Mu Sun, Bhumsuk Keam, T. M. Kim, Dae Seog Heo, Jin Seok Ahn, Yoon‐La Choi, Hye Sook Min, Yoon Kyung Jeon, K. Park